GATA-3 is a proto-oncogene in T-cell lymphoproliferative neoplasms (2022)
- Authors:
- Autor USP: PEREIRA, JULIANA - FM
- Unidade: FM
- DOI: 10.1038/s41408-022-00745-y
- Subjects: ONCOGENES; NEOPLASIAS; DIFERENCIAÇÃO CELULAR; PROLIFERAÇÃO CELULAR
- Agências de fomento:
- Language: Inglês
- Imprenta:
- Source:
- Título: Blood cancer journal
- ISSN: 2044-5385
- Volume/Número/Paginação/Ano: v. 12, n. 11, article ID 149, 13p, 2022
- Este periódico é de acesso aberto
- Este artigo NÃO é de acesso aberto
-
ABNT
GENG, Xiangrong et al. GATA-3 is a proto-oncogene in T-cell lymphoproliferative neoplasms. Blood cancer journal, v. 12, n. 11, 2022Tradução . . Disponível em: https://observatorio.fm.usp.br/handle/OPI/50412. Acesso em: 28 fev. 2026. -
APA
Geng, X., Wang, C., Gao, X., Chowdhury, P., Weiss, J., Villegas, J. A., et al. (2022). GATA-3 is a proto-oncogene in T-cell lymphoproliferative neoplasms. Blood cancer journal, 12( 11). doi:10.1038/s41408-022-00745-y -
NLM
Geng X, Wang C, Gao X, Chowdhury P, Weiss J, Villegas JA, Saed B, Perera T, Hu Y, Reneau J. GATA-3 is a proto-oncogene in T-cell lymphoproliferative neoplasms [Internet]. Blood cancer journal. 2022 ; 12( 11):[citado 2026 fev. 28 ] Available from: https://observatorio.fm.usp.br/handle/OPI/50412 -
Vancouver
Geng X, Wang C, Gao X, Chowdhury P, Weiss J, Villegas JA, Saed B, Perera T, Hu Y, Reneau J. GATA-3 is a proto-oncogene in T-cell lymphoproliferative neoplasms [Internet]. Blood cancer journal. 2022 ; 12( 11):[citado 2026 fev. 28 ] Available from: https://observatorio.fm.usp.br/handle/OPI/50412 - Adult T-Cell Leukemia/Lymphoma: A Clinical and Epidemiological Analysis at the Medicine School of Sao Paulo University
- How to manage lymphoid malignancies during novel 2019 coronavirus (CoVid-19) outbreak: a Brazilian task force recommendation
- Radiographic patterns of multiple myeloma in the jawbones of patients treated with intravenous bisphosphonates
- Comparison of Subcutaneous Versus Intravenous Administration of Rituximab As Maintenance Treatment for Follicular Lymphoma: Results From a Two-Stage, Phase IB Study
- Panoramic and skull imaging may aid in the identification of multiple myeloma lesions
- Estudo de células precuroras em leucemias agudas: identificação e fator de prognóstico das proteínas Bcl-2, Bax e CD95/Fas/APO-1
- Targeted therapy with nanatinostat and valganciclovir in recurrent EBV-positive lymphoid malignancies: a phase 1b/2 study
- 18 F-FDG pet interim and determination of cellular origin by immunohistochemistry identify a group of very good prognosis in patients with diffuse large B cell lymphoma in the rituximab era
- Immune reconstitution inflammatory syndrome-associated lymphoma: a retrospective Brazilian cohort
- Macrophage migration inhibitory factor and chemokine RANTES in young pediatric patients with congenital cardiac communications: relation to hemodynamic parameters and the presence of Down syndrome
Informações sobre o DOI: 10.1038/s41408-022-00745-y (Fonte: oaDOI API)
How to cite
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
